Von Willebrand factor in colorectal cancer

International Journal of Colorectal Disease

Volumn 17, Issue 1, 2002, Pages 42-45

  Damin, Daniel C ^a,b   Rosito, Mário A ^a   Gus, Pedro ^a   Roisemberg, Israel ^a   Bandinelli, Eliane ^a   Schwartsmann, Gilberto ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Lutheran University ^*  (Brazil)

Author keywords

Colon cancer; Colorectal carcinoma; Von Willebrand factor

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOELECTROPHORESIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; TUMOR VOLUME; BLOOD; CASE CONTROL STUDY; COLORECTAL TUMOR; METABOLISM; MIDDLE AGED;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOELECTROPHORESIS; MALE; MIDDLE AGED; PROGNOSIS; VON WILLEBRAND FACTOR;

EID: 0036355071     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003840100345     Document Type: Article

References (39)

1. Deans GT, Parks TG, Rowlands BJ, et al (1992) Prognostic factors in colorectal cancer. Br J Surg 79:608-613
2. Wilmink ABM (1997) Overview of the epidemiology of colorectal cancer. Dis Colon Rectum 40:483-493
3. Wolmark N, Fischer B, Wieand HS (1996) The prognostic value of the modifications of the Dukes' C class of colorectal cancer: analysis of the NSABP trials. Ann Surg 302:115-122
4. Cromwell JW, Aguilar JC (1998) The molecular basis of cancer metastasis. Semin Colon Rectal Surg 9:53-62
5. Gutman M, Fidler JF (1995) Biology of human colon cancer metastasis. World J Surg 19:226-234
6. Hart IR, Saini A (1995) Biology of tumor metastasis. Lancet 399:1453-1457
7. Folkman J (1995) Clinical applications of research on angiogenesis. N Engl J Med 333:1757-1763
8. Zhou Q, Zhao Y, Xu C, et al (1992) Increase in plasma thrombomodulin and decrease in plasma von Willebrand factor after regular radiotherapy in patients with cancer. Thromb Res 68:109-118
9. Hodak E, Tratner A, David M, et al (1993) Quantitative and qualitative assessment of plasma von Willebrand factor in classic Kaposi's sarcoma. J Am Acad Dermatol 28.2:217-221
10. Ruggeri ZM (1991) Structure and function of von Willebrand factor: relationship to von Willebrand disease. Mayo Clin Proc 66:847-861
11. Girma JP, Meyer D, Pannekock H, Sixma JJ (1987) Structure-function relationship of human von Willebrand factor. Blood 70:605-611
12. Ruggeri ZM (1997) Von Willebrand factor. J Clin Invest 99:559-564
13. Lufkin EG, Fass DN, O'Fallon WV, Bowie EJ (1979) Increased von Willebrand factor in diabetes mellitus. Metabolism 28:63-66
14. Giustolisi R, Musso R, Cacciola E, Russo M, Petralito A (1984) Abnormal plasma level of factor VIII/von Willebrand factor complex in myocardical infarction: expression of acute phase reaction or index of vascular endothelium damage? Thromb Haemost 51:408
15. Castillo R, Maragall A, Rodes J, Clemente C, Profitos J, Ordinas A (1977) Increased factor VIII complex and defective ristocetin-induced platelet aggregation in liver disease. Thromb Res 11:899-906
16. Pottinger BE, Read RC, Paleolog EM, Higgins PG, Pearson JD (1989) Von Willebrand factor is an acute phase reactant in man. Thromb Res 53:387-394
17. Gordon JL, Pottinger BE, Woo P, Rosenbaum J, Black C (1987) Plasma von Willebrand factor antigen in connective tissue disease. Ann Rheum Dis 46:441-447
18. Sweeney JD, Labuzetta BS, Hoerning, Fitzpatrick JE (1989) Platelet function and ABO blood group. Am J Clin Pathol 91:79-81
19. Zanetta L, Marcus SG, Vasile J, et al (1989) Angiogenesis factors upregulate endothelial cell expression of von Willebrand factor. Proc Am Cancer Res 39:40
20. Gasic GJ, Gasic TB, Galanti N, Johnson T, Murphy F (1973) Platelet-tumor cell interactions in mice. The hole of platelets in spread of malignant disease. Int J Cancer 11:704-718
21. Gasic GJ, Gasic TB, Stewart CC (1968) Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci USA 61:46-52
22. Marcum JM, McGill M, Batisda E, Ordinas A, Jamieson GA (1980) The interaction of platelets, tumor cells and vascular subendothelium. J Lab Clin Med 96:1046-1053
23. Ablin RJ, Bartkus JM, Gonder MJ (1988) Immunoquantitation of factor VIII-related antigen (von Willebrand factor antigen) in prostate cancer. Cancer Lett 40:283-289
24. Facchini V, Gadducci A, Baicchi U, Del-Bravo B, Vispi M, Teti G, Fioretti P (1988) Factor VIIIR: Ag plasma levels in patients with cervical and ovarian carcinoma. Eur J Oncol 9:87-93
25. Gadducci A, Baicchi U, Marrai R, et al (1993) Pretreatment plasma level of fibrinoptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with operable cervical cancer: influence of surgical-pathological stage, tumor size, histologic type, and lymph node status. Gynecol Oncol 49:354-358
26. Sweeney JD, Killion KM, Pruet CF, Spalding MB (1990) Von Willebrand factor in head and neck cancer. Cancer 11:2387-2389
27. Paczuski R, Bialkowska A, Kotschy M, Barduk D, Batlejewski (1999) Von Willebrand factor in plasma of patients with advanced stages of larynx cancer. Thromb Res 95:197-200
28. Turnbull RB Jr, Kyle K, Watson FR, Spratt J (1967) Cancer of the colon: the influence of non touch isolation technique on survival rates. Ann Surg 166:420-427
29. Zimmerman TS, Hoyer LW, Dickinson L, Edington TS (1975) Determination of the von Willebrand's disease antigen (factor VIII related antigen) in plasma by quantitative immunoelectrophoresis. J Lab Clin Med 86:152-159
30. Nierodizik ML, Plotkin A, Kajumo F, Karpatkin S (1991) Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J Clin Invest 87:229-236
31. Nierodzik ML, Kajumo F, Karpatkin S (1992) Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res 52:3267-3272
32. Oleksowicz L, Bhagwati N, DeLeon-Fernandez M (1999) Deficient activity of von Willebrand's factor-cleaving protease in patients with disseminated malignancies. Cancer Res 59:2244-2250
33. Floyd CM, Irani K, Kind PD, Kessler CM (1992) Von Willebrand factor interacts with malignant hematopoietic cell lines: evidence for the presence of specific binding sites and modification of von Willebrand factor structure and function. J Lab Clin Med 119:467-476
34. Grossi IM, Hatfield LA, Newcombe M, Taylor JD, Honn KV (1988) Role of tumor cell glycoproteins immunologically related to glycoproteins Ib and IIb/IIIa in tumor cell-platelet and tumor cell-matrix interactions. FASEB J 8:2385-2395
35. Dardik R, Savion N, Kaufmann Y, Varon D (1988) Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIa. Br J Cancer 77:2069-2075
36. Jass JR (1991) Pathologists' perspectives on colorectal cancer. Perspect Colon Rectal Surg 4:327-332
37. Steele G, Zamcheck N (1985) The use of carcinoembryonic antigen in the clinical management of patients with colorectal cancer. Cancer Detect Prev 8:421-427
38. Wolmark N, Fischer B, Wieand HS, et al (1984) The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP clinical trials. Ann Surg 199:375-382
39. Moertel CG, O'Fallon JR, GO VL, et al (1986) The preoperative carcinoembryonic antigen testing the diagnosis, staging, and prognosis of colorectal cancer. Cancer 58:603-611